<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Veelen, L.R. van</title>
    <link>http://repub.eur.nl/res/aut/3609/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation (Article)</title>
      <link>http://repub.eur.nl/res/pub/8414/</link>
      <pubDate>2006-01-01T00:00:00Z</pubDate>
      <description>V(D)J recombination of Ig and TCR loci is a stepwise process during which
      site-specific DNA double-strand breaks (DSBs) are made by RAG1/RAG2,
      followed by DSB repair by nonhomologous end joining. Defects in V(D)J
      recombination result in SCID characterized by absence of mature B and T
      cells. A subset of T-B-NK+ SCID patients is sensitive to ionizing
      radiation, and the majority of these patients have mutations in Artemis.
      We present a patient with a new type of radiosensitive T-B-NK+ SCID with a
      defect in DNA ligase IV (LIG4). To date, LIG4 mutations have only been
      described in a radiosensitive leukemia patient and in 4 patients with a
      designated LIG4 syndrome, which is associated with chromosomal
      instability, pancytopenia, and developmental and growth delay. The patient
      described here shows that a LIG4 mutation can also cause T-B-NK+ SCID
      without developmental defects. The LIG4-deficient SCID patient had an
      incomplete but severe block in precursor B cell differentiation, resulting
      in extremely low levels of blood B cells. The residual D(H)-J(H) junctions
      showed extensive nucleotide deletions, apparently caused by prolonged
      exonuclease activity during the delayed D(H)-J(H) ligation process. In
      conclusion, different LIG4 mutations can result in either a developmental
      defect with minor immunological abnormalities or a SCID picture with
      normal development.</description>
    </item> <item>
      <title>Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the pre-B-cell receptor checkpoint in bone marrow (Article)</title>
      <link>http://repub.eur.nl/res/pub/8235/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Severe combined immunodeficiency disease (SCID) can be immunologically
      classified by the absence or presence of T, B, and natural killer (NK)
      cells. About 30% of T(-)B(-)NK(+) SCID patients carry mutations in the
      recombination activating genes (RAG). Some T(-)B(-)NK(+) SCID patients
      without RAG gene mutations are sensitive to ionizing radiation, and
      several of these radiosensitive (RS) SCID patients were recently shown to
      have large deletions or truncation mutations in the Artemis gene, implying
      a role for Artemis in DNA double-strand break (dsb) repair. We identified
      5 RS-SCID patients without RAG gene mutations, 4 of them with Artemis gene
      mutations. One patient had a large genomic deletion, but the other 3
      patients carried simple missense mutations in conserved amino acid
      residues in the SNM1 homology domain of the Artemis protein.
      Extrachromosomal V(D)J recombination assays showed normal and precise
      signal joint formation, but inefficient coding joint formation in
      fibroblasts of these patients, which could be complemented by the
      wild-type Artemis gene. The cells containing the missense mutations in the
      SNM1 homology domain had the same recombination phenotype as the cells
      with the large deletion, indicating that these amino acid residues are
      indispensable for Artemis function. Immunogenotyping and immunophenotyping
      of bone marrow samples of 2 RS-SCID patients showed the absence of
      complete V(H)-J(H) gene rearrangements and consequently a complete B-cell
      differentiation arrest at the pre-B-cell receptor checkpoint-that is, at
      the transition from CyIgmu(-) pre-B-I cells to CyIgmu(+) pre-B-II cells.
      The completeness of this arrest illustrates the importance of Artemis at
      this stage of lymphoid differentiation.</description>
    </item>
  </channel>
</rss>